Comparative Study of Novel Ultradeformable Liposomes: Menthosomes, Transfersomes and Liposomes for Enhancing Skin Permeation of Meloxicam

被引:61
作者
Duangjit, Sureewan [1 ,2 ]
Obata, Yasuko [1 ]
Sano, Hiromu [1 ]
Onuki, Yoshinori [1 ]
Opanasopit, Praneet [2 ]
Ngawhirunpat, Tanasait [2 ]
Miyoshi, Tsubasa [3 ]
Kato, Satoru [3 ]
Takayama, Kozo [1 ]
机构
[1] Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan
[2] Silpakorn Univ, Fac Pharm, Dept Pharmaceut Technol, Nakhon Pathom 73000, Thailand
[3] Kwansei Gakuin Univ, Dept Phys, Chuo Ku, Kobe, Hyogo 6510073, Japan
关键词
menthosome; transfersome; liposome; skin permeation; meloxicam; menthol; LIPID VESICLES; TRANSDERMAL DELIVERY; STATISTICAL APPROACH; STRATUM-CORNEUM; IN-VITRO; DRUG; CARRIERS; MODEL; PERMEABILITY; FORMULATIONS;
D O I
10.1248/bpb.b13-00576
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study, novel ultradeformable liposomes (menthosomes; MTS), deformable liposomes (transfersomes; TFS) and conventional liposomes (CLP) were compared in their potential for transdermal delivery of meloxicam (MX). MTS, TFS and CLP were investigated for size, size distribution, zeta potential, elasticity, entrapment efficiency and stability. In vitro skin permeation using hairless mice skin was evaluated. Vesicular morphology was observed under freeze-fractured transmission electron microscopy (FF-TEM). Intrinsic thermal properties were performed using differential scanning calorimetry (DSC) and X-ray diffraction. The skin permeation mechanism was characterized using confocal laser scanning microscopy (CLSM). The results indicated that the difference in physicochemical characteristics of MTS, TFS and CLP affected the skin permeability. MTS and TFS showed higher flux of MX than CLP. CLSM image showed deformable vesicles mechanism for delivery of MX across the hairless mice skin. Our study suggested that ultradeformable and deformable liposomes (MTS and TFS) had a potential to use as transdermal drug delivery carriers for MX.
引用
收藏
页码:239 / 247
页数:9
相关论文
共 33 条
[11]   Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy [J].
Fang, Yi-Ping ;
Tsai, Yi-Hung ;
Wu, Pao-Chu ;
Huang, Yaw-Bin .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 356 (1-2) :144-152
[12]   Effect of cholesterol on the rigidity of saturated and unsaturated membranes: fluctuation and electrodeformation analysis of giant vesicles [J].
Gracia, Ruben Serral ;
Bezlyepkina, Natalya ;
Knorr, Roland L. ;
Lipowsky, Reinhard ;
Dimova, Rumiana .
SOFT MATTER, 2010, 6 (07) :1472-1482
[13]   Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study [J].
Gupta, PN ;
Mishra, V ;
Rawat, A ;
Dubey, P ;
Mahor, S ;
Jain, S ;
Chatterji, DP ;
Vyas, SP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 293 (1-2) :73-82
[14]   Multivariate statistical approach to optimizing sustained-release tablet formulations containing diltiazem hydrochloride as a model highly water-soluble drug [J].
Kikuchi, Shingo ;
Takayama, Kozo .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 386 (1-2) :149-155
[15]   Mechanical properties and stability measurement of cholesterol-containing liposome on mica by atomic force microscopy [J].
Liang, XM ;
Mao, GZ ;
Ng, KYS .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2004, 278 (01) :53-62
[16]   Structure and physicochemical properties of meloxicam, a new NSAID [J].
Luger, P ;
Daneck, K ;
Engel, W ;
Trummlitz, G ;
Wagner, K .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 4 (03) :175-187
[17]  
Obata Y, 1990, DRUG DES DELIV, V4, P319
[18]   Combined effects of ethanol and L-menthol on hairless rat stratum corneum investigated by synchrotron X-ray diffraction [J].
Obata, Yasuko ;
Hatta, Ichiro ;
Ohta, Noboru ;
Kunizawa, Naomi ;
Yagi, Naoto ;
Takayama, Kozo .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (03) :275-279
[19]   A statistical approach to the development of a transdermal delivery system for ondansetron [J].
Obata, Yasuko ;
Ashitaka, Yuriko ;
Kikuchi, Shingo ;
Isowa, Koichi ;
Takayama, Kozo .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 399 (1-2) :87-93
[20]  
Okusa T, 1997, DRUG DELIV SYST, V12, P327